Clinical Trials Browser

Phase 1/2 × OTHER_GOV × Burkitt Lymphoma × Clear all

NCT03263208 2017-10-20

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

Phase 1/2 Unknown

Burkitt Lymphoma